Effect of Stress Ball Use on Labor Pain and Birth Experience in Primiparous Women During Labor
Launched by HARRAN UNIVERSITY · May 30, 2025
Trial Information
Current as of August 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using a stress ball during labor can help reduce pain and improve the childbirth experience for first-time mothers. The researchers aim to find out if squeezing a stress ball during contractions can make labor less painful and more manageable. This method is considered a safe and non-invasive way to cope with labor pain, and it could be an easy tool for healthcare providers to use during childbirth.
To participate in this study, women must be between 18 and 35 years old, having their first baby, and at 37 to 42 weeks of pregnancy. They should not have any major health issues or complications during labor and must be willing to try this method without using pain medications. Participants will be randomly assigned to either use the stress ball or not, and their pain levels and childbirth experiences will be measured throughout labor and after delivery. This study hopes to provide valuable information on how simple techniques can enhance the childbirth experience for women.
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria:Inclusion Criteria
- • Aged between 18 and 35 years
- • Singleton, viable pregnancy
- • Being primiparous
- • Gestational age between 37 and 42 weeks
- • Having a Visual Analog Scale (VAS) pain score ≥1 during the intrapartum period
- • Absence of systemic or obstetric complications
- • No analgesics or pharmacological pain relief used during labor
- Exclusion Criteria:
- • Having a chronic illness affecting pain perception
- • Difficulty communicating
- • Need for medical intervention during labor (e.g., emergency cesarean section)
- • Ethical Approval and Informed Consent
- • The study will be conducted after receiving approval from the
About Harran University
Harran University is a distinguished academic institution committed to advancing healthcare through innovative research and clinical trials. With a focus on enhancing patient outcomes, the university leverages its multidisciplinary expertise to conduct rigorous scientific investigations. Harran University fosters collaboration among researchers, clinicians, and industry partners to explore novel therapeutic approaches and improve clinical practices. Through its dedication to ethical standards and patient safety, Harran University aims to contribute significantly to the body of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported